Arguments for and against HIV self-testing

Συγγραφείς: Wood BR, Ballenger C, Stekler JD

Πηγή: HIV/AIDS: Research and Palliative Care, Vol 2014, Iss default, Pp 117-126 (2014)

Θεματικοί όροι: Immunologic diseases. Allergy, RC581-607

Περιγραφή αρχείου: electronic resource

Relation: http://www.dovepress.com/arguments-for-and-against-hiv-self-testing-peer-reviewed-article-HIV; https://doaj.org/toc/1179-1373

Σύνδεσμος πρόσβασης: https://doaj.org/article/c21854e1032f490f88321a200e0f83a4

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection

Συγγραφείς: Hughes, SM, Levy, CN, Calienes, FL, Stekler, JD, Pandey, U, Vojtech, L, Berard, AR, Birse, K, Noel-Romas, L, Richardson, B

Πηγή: CELL REPORTS MEDICINE. 1(6):100096-100096

Σύνδεσμος πρόσβασης: http://kipublications.ki.se/Default.aspx?queryparsed=id:148643878

Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection

Συγγραφείς: Hughes, SM, Levy, CN, Calienes, FL, Stekler, JD, Pandey, U, Vojtech, L, Berard, AR, Birse, K, Noël-Romas, L, Richardson, B

Πηγή: bioRxiv.

Σύνδεσμος πρόσβασης: http://kipublications.ki.se/Default.aspx?queryparsed=id:

Effective strategies to promote HIV self-testing for men who have sex with men: Evidence from a mathematical model

Συγγραφείς: Hamilton, DT, Katz, DA, Luo, W, Stekler, JD, Rosenberg, ES, Sullivan, PS, Goodreau, SM, Cassels, S

Συνεισφορές: GEOGRAPHY

Πηγή: Epidemics
Epidemics, Vol 37, Iss, Pp 100518-(2021)

Θεματικοί όροι: Male, Epidemiology, Clinical Sciences, HIV self-testing, HIV Infections, Infectious and parasitic diseases, RC109-216, Network modeling, Article, HIV Testing, Sexual and Gender Minorities, 03 medical and health sciences, 0302 clinical medicine, Theoretical, Models, Health Sciences, Humans, Homosexuality, Male, Prevention, HIV transmission dynamics, Homosexuality, Models, Theoretical, 3. Good health, Infectious Diseases, Mental Health, Self-Testing, Public Health and Health Services, HIV/AIDS, Sexually Transmitted Infections, Public Health, Infection

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/34775299
https://doaj.org/article/c58d86984c8142778719cd99c3626b9d
https://www.sciencedirect.com/science/article/pii/S1755436521000645
https://escholarship.org/uc/item/0dn3w6qs
https://escholarship.org/content/qt0dn3w6qs/qt0dn3w6qs.pdf

Failure of serosorting to protect African American men who have sex with men from HIV infection.

Συγγραφείς: Golden MR, Dombrowski JC, Kerani RP, Stekler JD, Golden, Matthew R, Dombrowski, Julia C, Kerani, Roxanne P, Stekler, Joanne D

Πηγή: Sexually Transmitted Diseases; 2012 Sep, Vol. 39 Issue 9, p659-664, 6p

Randomized Controlled Trial of a HIV Prevention App to Increase Pre-exposure Prophylaxis Uptake Among Gay and Bisexual Men Who Have Sex With Men in the United States: The HealthMindr PrEP Study.

Συγγραφείς: Jones J; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Schneider I; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Valencia R; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Jenness SM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Butler G; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA., Castel AD; Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC., Kulie P; Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC., Stephenson R; Department of Systems, Populations and Leadership, School of Nursing, University of Michigan, Ann Arbor, MI., Stekler JD; Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA; and., Mena L; Department of Medicine, Emory University, Atlanta, GA., Sullivan PS; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.

Πηγή: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2025 Dec 15; Vol. 100 (5), pp. 425-434.

Τύπος έκδοσης: Journal Article; Randomized Controlled Trial

Στοιχεία περιοδικού: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

Ιατρικοί όροι (MeSH): HIV Infections*/prevention & control , Pre-Exposure Prophylaxis*/methods , Homosexuality, Male* , Mobile Applications* , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/administration & dosage , Sexual and Gender Minorities*, Humans ; Male ; Adult ; United States ; Middle Aged ; Young Adult ; Bisexuality

The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United States.

Συγγραφείς: Manabe YC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Hamill MM; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Palamountain KM; Kellogg School of Management, Northwestern University, Evanston, Illinois, USA., Achenbach CJ; Division of Infectious Diseases, Department of Medicine, Havey Institute for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Delaney KP; US Centers for Disease Control, Atlanta, Georgia, USA., Hsieh YH; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Jones JL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kirby RP; Kellogg School of Management, Northwestern University, Evanston, Illinois, USA., McFall SM; Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University, Evanston, Illinois, USA., Osburn WO; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ray SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Rothman RE; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Stekler JD; Department of Medicine, University of Washington, Seattle, Washington, USA., Katz DA; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.

Πηγή: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Oct 23. Date of Electronic Publication: 2025 Oct 23.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Preferences for HIV Pre-Exposure Prophylaxis Products and Delivery Models Among Cisgender Men, Transgender Persons, and Nonbinary Individuals Who Have Sex With Men in Seattle, Washington: A Discrete Choice Experiment.

Συγγραφείς: Violette LR; Department of Medicine, University of Washington, Seattle, WA.; Department of Epidemiology, University of Washington, Seattle, WA.; Harvard Medical School, Boston, MA.; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA., Delacruz J; Department of Global Health, University of Washington, Seattle, WA; and., Niemann LA; Department of Medicine, University of Washington, Seattle, WA., Cannon C; Department of Medicine, University of Washington, Seattle, WA.; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, WA., Stekler JD; Department of Medicine, University of Washington, Seattle, WA.; Department of Epidemiology, University of Washington, Seattle, WA.; Department of Global Health, University of Washington, Seattle, WA; and., Katz DA; Department of Global Health, University of Washington, Seattle, WA; and.

Πηγή: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2025 Oct 01; Vol. 100 (2), pp. 105-114.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Pre-Exposure Prophylaxis*/methods , HIV Infections*/prevention & control , Transgender Persons*/psychology , Patient Preference* , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/administration & dosage , Homosexuality, Male* , Sexual and Gender Minorities*/psychology, Humans ; Male ; Adult ; Washington ; Middle Aged ; Young Adult ; Female ; Choice Behavior

Development of a Highly Multiplexed RT-LAMP Assay for Coverage of Genetic Sequence Diversity.

Συγγραφείς: Gilligan-Steinberg SD; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Kline EC; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Wang Q; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Britton RJ; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Kim W; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Rupp JW; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Gu H; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Beck IA; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington 98109, United States., Hull IT; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Panpradist N; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States., Stekler JD; Department of Global Health, University of Washington, Seattle, Washington 98105, United States.; Department of Medicine, University of Washington, Seattle, Washington 98195, United States., Frenkel LM; Department of Medicine, University of Washington, Seattle, Washington 98195, United States.; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington 98109, United States., Drain PK; Department of Global Health, University of Washington, Seattle, Washington 98105, United States.; Department of Medicine, University of Washington, Seattle, Washington 98195, United States., Lai JJ; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.; Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan., Lutz BR; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.

Πηγή: Analytical chemistry [Anal Chem] 2025 Feb 25; Vol. 97 (7), pp. 4005-4013. Date of Electronic Publication: 2025 Feb 13.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6882 (Electronic) Linking ISSN: 00032700 NLM ISO Abbreviation: Anal Chem Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Nucleic Acid Amplification Techniques*/methods , Genetic Variation* , HIV-1*/genetics , Molecular Diagnostic Techniques*/methods , RNA, Viral*/genetics, Humans ; HIV Infections/diagnosis ; HIV Infections/virology ; DNA Primers/genetics

SCR Protocol: LAMP assay

Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study.

Συγγραφείς: Jones J; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Butler G; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Woody M; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Sheets M; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Castel AD; Department of Epidemiology, The George Washington University, Washington, District of Columbia, USA., Kulie P; Department of Epidemiology, The George Washington University, Washington, District of Columbia, USA., Scheim AI; Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, Pennsylvania, USA., Reisner SL; Department of Epidemiology, Harvard University, Boston, Massachusetts, USA., Valencia R; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Wang M; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Stephenson R; Department of Systems, Populations and Leadership, University of Michigan, Ann Arbor, Michigan, USA., Stekler JD; Division of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, USA., Sullivan PS; Department of Epidemiology, Emory University, Atlanta, Georgia, USA.

Πηγή: Transgender health [Transgend Health] 2024 Dec 16; Vol. 9 (6), pp. 573-581. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101691357 Publication Model: eCollection Cited Medium: Print ISSN: 2688-4887 (Print) Linking ISSN: 2380193X NLM ISO Abbreviation: Transgend Health Subsets: PubMed not MEDLINE

Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA.

Συγγραφείς: McMahan VM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Atkins DL; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Buckler S; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Violette LR; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Niemann L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Frank N; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Kimiam Waters; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Herrera Perales LE; Seattle's LGBTQ+ Center (formerly Gay City), Seattle, WA, USA., Viquez L; Seattle's LGBTQ+ Center (formerly Gay City), Seattle, WA, USA., Tung E; Kelley-Ross Pharmacy Group, Seattle, WA, USA., Stekler JD; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.

Πηγή: International journal of STD & AIDS [Int J STD AIDS] 2024 Jul; Vol. 35 (8), pp. 635-643. Date of Electronic Publication: 2024 Apr 17.

Τύπος έκδοσης: Journal Article; Randomized Controlled Trial

Στοιχεία περιοδικού: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE

Ιατρικοί όροι (MeSH): HIV Infections*/prevention & control , HIV Infections*/drug therapy , Methamphetamine* , Pre-Exposure Prophylaxis* , Anti-HIV Agents*/therapeutic use , Assessment of Medication Adherence*, Humans ; Male ; Adult ; Female ; Amphetamine-Related Disorders ; Washington ; Sexual Behavior ; Patient Selection ; Middle Aged ; Text Messaging ; Peer Group

Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling study.

Συγγραφείς: Cox SN; Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., Wu L; Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., Wittenauer R; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Pharmacy, University of Washington, Seattle, WA, USA., Clark S; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Pharmacy, University of Washington, Seattle, WA, USA., Roberts DA; Department of Epidemiology, University of Washington, Seattle, WA, USA., Nwogu IB; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Pharmacy, University of Washington, Seattle, WA, USA., Vitruk O; Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., Kuo AP; Department of Pharmacy, University of Washington, Seattle, WA, USA., Johnson C; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland., Jamil MS; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland., Sands A; Regulation and Prequalification Department, World Health Organization, Geneva, Switzerland., Schaefer R; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland., Kisia C; World Health Organization - Kenya Country Office, Nairobi, Kenya., Baggaley R; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland., Stekler JD; Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Akullian A; Department of Global Health, University of Washington, Seattle, WA, USA; Institute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA., Sharma M; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: msharma1@uw.edu.

Πηγή: The lancet. HIV [Lancet HIV] 2024 Mar; Vol. 11 (3), pp. e167-e175. Date of Electronic Publication: 2024 Jan 29.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Ιατρικοί όροι (MeSH): HIV Infections*/diagnosis , HIV Infections*/drug therapy , HIV Infections*/epidemiology , Pre-Exposure Prophylaxis* , Anti-HIV Agents*/therapeutic use , Nucleic Acids*/therapeutic use, Adult ; Humans ; Kenya/epidemiology ; Self-Testing ; Emtricitabine/therapeutic use ; Reverse Transcriptase Inhibitors/therapeutic use ; HIV Testing

Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs.

Συγγραφείς: Tsui JI; Department of Medicine, University of Washington School of Medicine, Division of General Internal Medicine University of Washington, Seattle, WA, United States., Gojic AJ; Department of Medicine, University of Washington School of Medicine, Division of General Internal Medicine University of Washington, Seattle, WA, United States., Pierce KA; Kelley-Ross Pharmacy Group, Seattle, WA, United States., Tung EL; Kelley-Ross Pharmacy Group, Seattle, WA, United States.; Department of Pharmacy, University of Washington, Seattle, WA, United States., Connolly NC; Department of Medicine, University of Washington School of Medicine, Division of General Internal Medicine University of Washington, Seattle, WA, United States., Radick AC; Department of Medicine, University of Washington School of Medicine, Division of General Internal Medicine University of Washington, Seattle, WA, United States., Hunt RR; Des Moines University College of Osteopathic Medicine, Des Moines, IA, United States., Sandvold R; Hepatitis Education Project, Seattle, WA, United States., Taber K; Hepatitis Education Project, Seattle, WA, United States., Ninburg M; Hepatitis Education Project, Seattle, WA, United States., Kubiniec RH; Evergreen Treatment Services, Seattle, WA, United States., Scott JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States., Hansen RN; Kelley-Ross Pharmacy Group, Seattle, WA, United States.; Department of Pharmacy, University of Washington, Seattle, WA, United States.; Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States., Stekler JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States., Austin EJ; Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States., Williams EC; Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States.; Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle WA, United States., Glick SN; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States.; HIV/STI/HCV Program, Public Health - Seattle & King County, Seattle WA, United States.

Πηγή: Drug and alcohol dependence reports [Drug Alcohol Depend Rep] 2023 Dec 23; Vol. 10, pp. 100213. Date of Electronic Publication: 2023 Dec 23 (Print Publication: 2024).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918350383506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-7246 (Electronic) Linking ISSN: 27727246 NLM ISO Abbreviation: Drug Alcohol Depend Rep Subsets: PubMed not MEDLINE

Efficient Expansion of a Behavioral Survey to Assess Sex, Gender, and Behavioral Risk Among Transgender and Nonbinary Individuals: HMU! ( H IV Prevention for M ethamphetamine U sers).

Συγγραφείς: Frank N; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; HIV/STD Program, Public Health-Seattle and King County, Seattle, Washington, USA., McMahan VM; Department of Medicine, University of Washington, Seattle, Washington, USA., Violette LR; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Martin A; HIV/STD Program, Public Health-Seattle and King County, Seattle, Washington, USA., Glick SN; Department of Medicine, University of Washington, Seattle, Washington, USA.; HIV/STD Program, Public Health-Seattle and King County, Seattle, Washington, USA., Stekler JD; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.

Πηγή: Transgender health [Transgend Health] 2023 Oct 04; Vol. 8 (5), pp. 472-476. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101691357 Publication Model: eCollection Cited Medium: Print ISSN: 2688-4887 (Print) Linking ISSN: 2380193X NLM ISO Abbreviation: Transgend Health Subsets: PubMed not MEDLINE

Preferences for and Experiences of an HIV-Prevention Mobile App Designed for Transmasculine People: Pilot Feasibility Trial and Qualitative Investigation.

Συγγραφείς: Jones J; Department of Epidemiology, Emory University, Atlanta, GA, United States., Butler G; Department of Epidemiology, Emory University, Atlanta, GA, United States., Woody M; Department of Epidemiology, Emory University, Atlanta, GA, United States., Castel AD; Department of Epidemiology, George Washington University, Washington, DC, DC, United States., Kulie P; Department of Epidemiology, George Washington University, Washington, DC, DC, United States., Sheets M; Department of Epidemiology, Emory University, Atlanta, GA, United States., Scheim AI; Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, PA, United States., Reisner SL; Department of Epidemiology, Harvard University, Boston, MA, United States., Valencia R; Department of Epidemiology, Emory University, Atlanta, GA, United States., Wang M; Department of Epidemiology, Emory University, Atlanta, GA, United States., Stekler JD; Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, United States., Sullivan PS; Department of Epidemiology, Emory University, Atlanta, GA, United States., Stephenson R; Department of Systems Populations, and Leadership, University of Michigan, Ann Arbor, MI, United States.

Πηγή: JMIR formative research [JMIR Form Res] 2023 Sep 21; Vol. 7, pp. e51055. Date of Electronic Publication: 2023 Sep 21.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101726394 Publication Model: Electronic Cited Medium: Internet ISSN: 2561-326X (Electronic) Linking ISSN: 2561326X NLM ISO Abbreviation: JMIR Form Res Subsets: PubMed not MEDLINE

Could Home Human Immunodeficiency Virus Self-Testing Ever Become a Game Changer?

Συγγραφείς: Wood BR; Department of Medicine, University of Washington, Seattle, Washington, USA., Stekler JD; Department of Medicine, University of Washington, Seattle, Washington, USA.

Πηγή: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 May 03; Vol. 76 (9), pp. 1681-1684.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Ιατρικοί όροι (MeSH): HIV Infections*/diagnosis, Humans ; United States ; Self-Testing ; HIV

Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project DETECT.

Συγγραφείς: Stekler JD; Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Violette LR; Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Niemann LA; Department of Medicine, University of Washington, Seattle, WA, USA., McMahan VM; San Francisco Department of Public Health, San Francisco, CA, USA., Katz DA; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Chavez PR; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Clark HA; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Cornelius-Hudson A; Department of Medicine, University of Washington, Seattle, WA, USA., McDougal SJ; Department of Medicine, University of Washington, Seattle, WA, USA., Delaney KP; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Πηγή: International journal of STD & AIDS [Int J STD AIDS] 2023 May; Vol. 34 (6), pp. 385-394. Date of Electronic Publication: 2023 Jan 26.

Τύπος έκδοσης: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural

Στοιχεία περιοδικού: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE

Ιατρικοί όροι (MeSH): HIV Seropositivity*/drug therapy , HIV Infections*/diagnosis , HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use, Humans ; Longitudinal Studies ; Seroconversion

Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.

Συγγραφείς: Austin EJ; Department of Health Systems and Population Health, University of Washington, Seattle WA, United States. Electronic address: austie@uw.edu., Gojic AJ; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States., Bhatraju EP; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States., Pierce KA; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States., Pickering EI; Department of Social and Behavioral Sciences, Yale School of Public Health, United States., Tung EL; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States., Scott JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States., Hansen RN; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States., Glick SN; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States; HIV/STD Program, Public Health - Seattle & King County, Seattle WA, United States., Stekler JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States., Connolly NC; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States., Villafuerte S; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research)., McPadden M; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research)., Deutsch S; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research)., Ninburg M; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research)., Kubiniec R; Evergreen Treatment Services, Seattle WA, United States., Williams EC; Department of Health Systems and Population Health, University of Washington, Seattle WA, United States; Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle WA, United States., Tsui JI; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States.

Πηγή: The International journal on drug policy [Int J Drug Policy] 2023 Jan; Vol. 111, pp. 103924. Date of Electronic Publication: 2022 Dec 13.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9014759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4758 (Electronic) Linking ISSN: 09553959 NLM ISO Abbreviation: Int J Drug Policy Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Substance Abuse, Intravenous*/complications , Substance Abuse, Intravenous*/drug therapy , Patient Navigation* , Drug Users* , Hepatitis C, Chronic*/drug therapy , Hepatitis C*/drug therapy , Physicians*, Humans ; Hepacivirus ; Pharmacists ; Pharmaceutical Preparations ; Antiviral Agents/therapeutic use

Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).

Συγγραφείς: Mayer KH; The Fenway Institute, Fenway Health, Harvard Medical School, Harvard University, 1340 Boylston St, 02215, Boston, MA, United States. kmayer@fenwayhealth.org., Yuhas K; Statistical Center for HIV/AIDS Research (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Amico KR; University of Michigan School of Public Health, Ann Arbor, MI, United States., Wilkin T; Weill Cornell Medicine, New York, NY, United States., Landovitz RJ; UCLA Center for Clinical AIDS Research & Education, Los Angeles, CA, United States., Richardson P; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Marzinke MA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Hendrix CW; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Eshleman SH; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Cottle LM; Seagen, Bothell, WA, United States., Marcus C; HIV Clinical Trials Unit, University of North Carolina, Chapel Hill, NC, United States., Chege W; Clinical Prevention Research Branch, Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States., Rinehart AR; Global HIV Prevention Strategy, ViiV Healthcare - Research Triangle Park, Research Triangle Park, NC, United States., Rooney JF; Medical Affairs, Gilead Sciences, 12. FHI 360, Foster City, Durham, CA, NC, United States., Andrew P; FHI 360, Durham, NC, United States., Salata RA; Department of Medicine, Case Western Reserve University, Cleveland, OH, United States., Magnus M; Milken Institute School of Public Health, George Washington University, Washington, DC, United States., Farley JE; Johns Hopkins University School of Medicine, Baltimore, MD, United States., Liu AY; San Francisco Department of Public Health, Bridge HIV, San Francisco, CA, United States., Frank I; Hospital of the University of Pennsylvania, Philadelphia, PA, United States., Ho K; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Santana J; University of Puerto Rico, San Juan, Puerto Rico., Stekler JD; University of Washington School of Medicine, Seattle, WA, United States., Chen YQ; Statistical Center for HIV/AIDS Research (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States., McCauley M; FHI 360, Durham, NC, United States., Gulick RM; Weill Cornell Medicine, New York, NY, United States.

Συλλογικό Έργο: HPTN 069/ACTG 5305 Study Team

Πηγή: AIDS and behavior [AIDS Behav] 2022 Dec; Vol. 26 (12), pp. 4107-4114. Date of Electronic Publication: 2022 Jun 10.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Pre-Exposure Prophylaxis* , Anti-HIV Agents*/therapeutic use , HIV Infections*/drug therapy , HIV Infections*/epidemiology , HIV Infections*/prevention & control , Sexual and Gender Minorities*, Male ; Female ; Humans ; Emtricitabine/therapeutic use ; Tenofovir/therapeutic use ; Maraviroc/therapeutic use ; Homosexuality, Male ; Medication Adherence ; Sexual Behavior ; Anti-Retroviral Agents/therapeutic use

Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.

Συγγραφείς: Barry MP; Department of Epidemiology, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 8th Floor, Box 351619, Seattle, WA, 98195, USA.; HIV/STD Program, Public Health - Seattle and King County, 401 5th Ave. Suite 1300, Seattle, WA, 98104, USA., Austin EJ; Department of Health Systems and Population Health, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 4th Floor, Box 351621, Seattle, WA, 98195, USA., Bhatraju EP; Division of General Internal Medicine, Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Avenue, Box 359780, Seattle, WA, 98104, USA., Glick SN; HIV/STD Program, Public Health - Seattle and King County, 401 5th Ave. Suite 1300, Seattle, WA, 98104, USA.; Division of Allergy and Infectious Diseases, University of Washington, 1959 NE Pacific St., Box 356423, Seattle, WA, 98195, USA., Stekler JD; Department of Epidemiology, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 8th Floor, Box 351619, Seattle, WA, 98195, USA.; Division of Allergy and Infectious Diseases, University of Washington, 1959 NE Pacific St., Box 356423, Seattle, WA, 98195, USA.; Department of Global Health, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 7th Floor, Seattle, WA, 98195, USA., Tung EL; Kelley-Ross Pharmacy Group, Seattle, WA, USA.; Department of Pharmacy, University of Washington, H375 Health Science Building, Box 357630, Seattle, WA, 98195-7630, USA., Hansen RN; Department of Health Systems and Population Health, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 4th Floor, Box 351621, Seattle, WA, 98195, USA.; Kelley-Ross Pharmacy Group, Seattle, WA, USA.; Department of Pharmacy, University of Washington, H375 Health Science Building, Box 357630, Seattle, WA, 98195-7630, USA., Williams EC; Department of Health Systems and Population Health, Hans Rosling Center, School of Public Health, University of Washington, 3980 15th Ave. NE, 4th Floor, Box 351621, Seattle, WA, 98195, USA.; Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research and Development, VA Puget Sound, 1660 South Columbia Way, Building 101, Room 4E51, Seattle, WA, 98108, USA., Gojic AJ; Division of General Internal Medicine, Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Avenue, Box 359780, Seattle, WA, 98104, USA., Pickering EI; Division of General Internal Medicine, Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Avenue, Box 359780, Seattle, WA, 98104, USA.; Department of Social and Behavioral Sciences, Yale School of Public Health, 60 College Street, Suite 316, New Haven, CT, 06510, USA., Tsui JI; Division of General Internal Medicine, Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Avenue, Box 359780, Seattle, WA, 98104, USA. tsuij@uw.edu.

Πηγή: Harm reduction journal [Harm Reduct J] 2022 Nov 01; Vol. 19 (1), pp. 121. Date of Electronic Publication: 2022 Nov 01.

Τύπος έκδοσης: Journal Article; Research Support, N.I.H., Extramural

Στοιχεία περιοδικού: Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Pre-Exposure Prophylaxis* , Substance Abuse, Intravenous*/epidemiology , Drug Users* , Anti-HIV Agents*/therapeutic use , HIV Infections*/prevention & control , Hepatitis C*/drug therapy, Humans ; Hepacivirus ; Pilot Projects